LGD-4033

LGD-4033 BY

Tablets

DRUG COMPOSITION

1 tablet contains:
- active substance: ligandrol 30 mg;
- auxiliary substances:

DRUG DESCRIPTION

PHARMACEUTICAL FORM

Tablets.

PHARMACEUTICAL GROUP AND ATC CODE

Selective Androgen Receptor Modulator.

PHARMACOLOGICAL PROPERTIES

PROFILE

Half life: -
Routes of administration: by mouth
Dosage forms: (Men): -; (Women): -
Acne: -
Water retention: not a steroid
High blood pressure: no
Hepatotoxicity: no
Aromatase: no
Decreased HPTA function (own testosterone production): very low
Anabolic activity: None
Androgenic activity: Not a steroid
Detection time:

THERAPEUTICAL INDICATIONS

DOSES AND METHOD OF ADMINISTRATION

SIDE EFFECTS

CONTRAINDICATIONS

OVERDOSE

INTERACTIONS WITH OTHER DRUGS

PRESENTATION, PACKAGING

30 mg tablets.
30 tablets in sachets.

STORAGE

Store in a dry place and away from light at 15-25 ° C. Keep out of the reach and sight of children.

LEGAL STATUS

It is issued with prescription.

DATE OF LAST TEXT CHECKS

March 2020

NAME AND ADDRESS OF THE MANUFACTURER

India